• Citer

A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV non-small cell lung cancer

par Ramlau, Rodryg;Quoix, Elisabeth;Rolski, Janusz;Pless, Miklos;Lena, Herve;Lévy, Eric;Krzakowski, MacIej;Hess, Dagmar;Tartour, Eric;Chenard, Marie-Pierre;Limacher, Jean-Marc;Bizouarne, Nadine;Acres, Bruce;Halluard, Céline;Velu, Thierry
Référence Journal of Thoracic Oncology, 3, 7, page (735-744)
Publication Publié, 2008-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV non-small cell lung cancer
Auteur:	Ramlau, Rodryg; Quoix, Elisabeth; Rolski, Janusz; Pless, Miklos; Lena, Herve; Lévy, Eric; Krzakowski, MacIej; Hess, Dagmar; Tartour, Eric; Chenard, Marie-Pierre; Limacher, Jean-Marc; Bizouarne, Nadine; Acres, Bruce; Halluard, Céline; Velu, Thierry
Informations sur la publication:	Journal of Thoracic Oncology, 3, 7, page (735-744)
Statut de publication:	Publié, 2008-07
Sujet CREF:	Cancérologie
	Pneumologie
Mots-clés:	Chemotherapy
	MUC1
	MVA
	Non-small cell lung cancer
	Phase II study
	Recombinant viral vector
	Vaccine
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1556-0864
	info:doi/10.1097/JTO.0b013e31817c6b4f
	info:pii/0124389420080700000008
	info:scp/50349090322
	info:pmid/18594319